Skip to main content
Equibles
CTXR logo

CTXR · Citius Pharmaceuticals, Inc.

Track CTXR — free

Use CTXR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CTXR

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.60 -0.03 (-4.28%) At close · Aug 28
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We will need to raise additional capital in the future to support our operations beyond November 2026, which raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$17.03M
Shares
27.45M

Citius Pharmaceuticals, Inc. Earnings Call Transcripts

Quarterly earnings calls for Citius Pharmaceuticals, Inc. (CTXR), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Key facts CIK 1506251 CUSIP 17322U306 13F (30d) 36 filings 36 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)